Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease
Part of paid clinical trials in Houston, Texas.
- Sponsor
- Baylor College of Medicine
- Study ID
- NCT04740580
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 55 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- Glycine — DIETARY_SUPPLEMENTThe active arm will supplement a combination of glycine and N-acetylcysteine (GlyNAC)
- N-acetylcysteine — DIETARY_SUPPLEMENTThe active arm will supplement a combination of glycine and N-acetylcysteine (GlyNAC)
- Alanine — DIETARY_SUPPLEMENTThe placebo arm will supplement Alanine
Study Details
Alzheimer's disease (AD) is associated with significant, progressive cognitive decline. Key defects in mitochondrial fuel metabolism insulin resistance, inflammation and decreased brain glucose uptake are linked to AD. This trial will investigate the effects of supplementing glycine and N-acetylcysteine vs. alanine as placebo on these defects in AD, and examine the effects on cognition.
Key Dates
- Start date
- Feb 15, 2022
- Status verified
- Jun 2025
- Primary completion
- Apr 30, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 52 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: Glycine plus N-acetylcysteineGlycine and cysteine are amino-acid (protein) precursors of glutathione. Cysteine is provided as N-acetylcysteine
- Placebo Comparator: AlanineAlanine is an amino-acid (protein), and not a precursor of glutathione synthesis
Primary Outcome Measure
Cognition [ Time Frame: Day 0 of supplementation, and 12-weeks and 24-weeks after starting supplementation ]
Central Contacts
- Rajagopal V Sekhar, M.D.7137983908
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Baylor College of Medicine | Houston | Texas | 77030 |
Find similar trials in Houston, TX
By condition
By specialty
By research site
Related Studies
- Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's DiseasePHASE4 · Recruiting · University of Texas at Austin · Austin, Texas
- Longitudinal Early-onset Alzheimer's Disease Study ProtocolRecruiting · Indiana University · Sun City, Arizona
- ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's DiseaseRecruiting · InSightec · Delray Beach, Florida
- Trial-Ready Cohort-Down Syndrome (TRC-DS)Recruiting · University of Southern California · Phoenix, Arizona